Back to Search
Start Over
Pharmacological Treatment for Social Cognition: Current Evidence
- Source :
- International Journal of Molecular Sciences, International Journal of Molecular Sciences, Vol 22, Iss 7457, p 7457 (2021)
- Publication Year :
- 2021
- Publisher :
- MDPI, 2021.
-
Abstract
- Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ.
- Subjects :
- Social Cognition
QH301-705.5
medicine.medical_treatment
Review
Catalysis
Pharmacological treatment
Inorganic Chemistry
03 medical and health sciences
0302 clinical medicine
Cognition
pharmacological treatment
Social cognition
medicine
Animals
Humans
In patient
Physical and Theoretical Chemistry
Biology (General)
Cognitive impairment
Antipsychotic
Molecular Biology
QD1-999
Spectroscopy
Standard treatment
Organic Chemistry
Schizophrenia
Antipsychotic Agents
General Medicine
medicine.disease
030227 psychiatry
Computer Science Applications
antipsychotic
schizophrenia
Chemistry
Psychology
030217 neurology & neurosurgery
Clinical psychology
Subjects
Details
- Language :
- English
- ISSN :
- 14220067
- Volume :
- 22
- Issue :
- 14
- Database :
- OpenAIRE
- Journal :
- International Journal of Molecular Sciences
- Accession number :
- edsair.doi.dedup.....fb9c24d08ac5c6957f798c39534716d7